By Michele Maatouk
Date: Tuesday 06 Jan 2026
(Sharecast News) - US biotech firm Amgen said on Tuesday that it has bought Dark Blue Therapeutics, a UK biotechnology company specialising in cancer treatments, for up to $840m.
| SEP cashes in as US giant Amgen buys cancer drug... | 26-Jan-2011 | The Scotsman |
| Amgen Buys a Cancer Drug Maker | 25-Jan-2011 | New York Times |
| Tech Ticker | 16-Dec-2010 | BayArea.com |
| Amgen drug delayed spread of prostate cancer to ... | 15-Dec-2010 | LA Times |
| Business Briefing | 24-Dec-2009 | LA Times |
| Currency | US Dollars |
| Share Price | $ 419.38 |
| Change Today | $ 4.17 |
| % Change | 1.00 % |
| 52 Week High | $419.60 |
| 52 Week Low | $271.18 |
| Volume | 2,559,616 |
| Shares Issued | 538.80m |
| Market Cap | $225,962m |
| Beta | 0.02 |
| RiskGrade | 100 |
| Time | Volume / Share Price |
| 15:59 | 344 @ $419.46 |
| 15:59 | 379 @ $419.45 |
| 15:59 | 165 @ $419.45 |
| 15:59 | 40 @ $419.45 |
| 15:59 | 40 @ $419.45 |
You are here: research